Previous 10 | Next 10 |
CPS Technologies (NASDAQ: CPSH ) +71% on Q1 results . More news on: CPS Technologies Corporation, Medigus Ltd., Predictive Oncology Inc., Stocks on the move, , Read more ...
MARLBOROUGH, Mass. , May 4, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced dat...
MARLBOROUGH, Mass. , April 2, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today annou...
Thinly traded nano cap Phio Pharmaceuticals ( PHIO -10.9% ) slips on a 7x surge in volume in reaction to its direct sale of ~1.7M common shares at $2.335 per share to several institutional investors who will also receive 5 1/2-year warrants to purchase up to the same number of common sha...
MARLBOROUGH, Mass. , March 31, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced ...
SG Blocks (NASDAQ: SGBX ) +100% on Q4 results .. More news on: SG Blocks, Inc., EyeGate Pharmaceuticals, Inc., Kiniksa Pharmaceuticals, Ltd., Stocks on the move, , Read more ...
MARLBOROUGH, Mass. , March 31, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced ...
Phio Pharmaceuticals (NASDAQ: PHIO ): Q4 GAAP EPS of -$4.69. More news on: Phio Pharmaceuticals Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...
MARLBOROUGH, Mass. , March 26, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today reported its fi...
OpGen (NASDAQ: OPGN ) +74% on being beneficiaries related to COVID-19. More news on: OpGen, Inc., BioNTech SE, Neon Therapeutics, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Phio Pharmaceuticals Corp. Company Name:
PHIO Stock Symbol:
NASDAQ Market:
Phio Pharmaceuticals Corp. Website:
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells...
Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to ...
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced i...